Image1_Fatty acid metabolism prognostic signature predicts tumor immune microenvironment and immunotherapy, and identifies tumorigenic role of MOGAT2 in lung adenocarcinoma.tif by Denggang Fu (5082062)

“…</p>Methods<p>We developed a prognostic signature comprising 10 FAM-related genes (GPR115, SOAT2, CDH17, MOGAT2, COL11A1, TCN1, LGR5, SLC34A2, RHOV, and DKK1) using data from LUAD patients in The Cancer Genome Atlas (TCGA). …”

Image10_Suppression of PTRF Alleviates Post-Infectious Irritable Bowel Syndrome via Downregulation of the TLR4 Pathway in Rats.TIF by Hui-hui Zhou (11532046)

“…<p>Background: Accumulating evidence suggests that the polymerase I and transcript release factor (PTRF), a key component of the caveolae structure on the plasma membrane, plays a pivotal role in suppressing the progression of colorectal cancers. …”

Table_1_Associations Between CAMKK1 Polymorphism rs7214723 and the Prognosis of Patients With Lung Cancer.docx by Haorui Zhang (6751946)

“…Relative to the TT + TC genotypes, the rs7214723 recessive CC genotype was also associated with a decreased risk of death in patients aged < 60 years (CC vs. …”

Image7_Suppression of PTRF Alleviates Post-Infectious Irritable Bowel Syndrome via Downregulation of the TLR4 Pathway in Rats.TIF by Hui-hui Zhou (11532046)

“…<p>Background: Accumulating evidence suggests that the polymerase I and transcript release factor (PTRF), a key component of the caveolae structure on the plasma membrane, plays a pivotal role in suppressing the progression of colorectal cancers. …”

Image4_Suppression of PTRF Alleviates Post-Infectious Irritable Bowel Syndrome via Downregulation of the TLR4 Pathway in Rats.TIF by Hui-hui Zhou (11532046)

“…<p>Background: Accumulating evidence suggests that the polymerase I and transcript release factor (PTRF), a key component of the caveolae structure on the plasma membrane, plays a pivotal role in suppressing the progression of colorectal cancers. …”

DataSheet2_Fatty acid metabolism prognostic signature predicts tumor immune microenvironment and immunotherapy, and identifies tumorigenic role of MOGAT2 in lung adenocarcinoma.pdf by Denggang Fu (5082062)

“…</p>Methods<p>We developed a prognostic signature comprising 10 FAM-related genes (GPR115, SOAT2, CDH17, MOGAT2, COL11A1, TCN1, LGR5, SLC34A2, RHOV, and DKK1) using data from LUAD patients in The Cancer Genome Atlas (TCGA). …”

Image8_Suppression of PTRF Alleviates Post-Infectious Irritable Bowel Syndrome via Downregulation of the TLR4 Pathway in Rats.TIF by Hui-hui Zhou (11532046)

“…<p>Background: Accumulating evidence suggests that the polymerase I and transcript release factor (PTRF), a key component of the caveolae structure on the plasma membrane, plays a pivotal role in suppressing the progression of colorectal cancers. …”

Image1_Suppression of PTRF Alleviates Post-Infectious Irritable Bowel Syndrome via Downregulation of the TLR4 Pathway in Rats.TIF by Hui-hui Zhou (11532046)

“…<p>Background: Accumulating evidence suggests that the polymerase I and transcript release factor (PTRF), a key component of the caveolae structure on the plasma membrane, plays a pivotal role in suppressing the progression of colorectal cancers. …”

Table1_Suppression of PTRF Alleviates Post-Infectious Irritable Bowel Syndrome via Downregulation of the TLR4 Pathway in Rats.XLS by Hui-hui Zhou (11532046)

“…<p>Background: Accumulating evidence suggests that the polymerase I and transcript release factor (PTRF), a key component of the caveolae structure on the plasma membrane, plays a pivotal role in suppressing the progression of colorectal cancers. …”

Image12_Suppression of PTRF Alleviates Post-Infectious Irritable Bowel Syndrome via Downregulation of the TLR4 Pathway in Rats.TIF by Hui-hui Zhou (11532046)

“…<p>Background: Accumulating evidence suggests that the polymerase I and transcript release factor (PTRF), a key component of the caveolae structure on the plasma membrane, plays a pivotal role in suppressing the progression of colorectal cancers. …”

Image9_Suppression of PTRF Alleviates Post-Infectious Irritable Bowel Syndrome via Downregulation of the TLR4 Pathway in Rats.TIF by Hui-hui Zhou (11532046)

“…<p>Background: Accumulating evidence suggests that the polymerase I and transcript release factor (PTRF), a key component of the caveolae structure on the plasma membrane, plays a pivotal role in suppressing the progression of colorectal cancers. …”

Image6_Fatty acid metabolism prognostic signature predicts tumor immune microenvironment and immunotherapy, and identifies tumorigenic role of MOGAT2 in lung adenocarcinoma.tif by Denggang Fu (5082062)

“…</p>Methods<p>We developed a prognostic signature comprising 10 FAM-related genes (GPR115, SOAT2, CDH17, MOGAT2, COL11A1, TCN1, LGR5, SLC34A2, RHOV, and DKK1) using data from LUAD patients in The Cancer Genome Atlas (TCGA). …”

Applying value-based strategies to accelerate access to novel cancer medications: guidance from the Oncology Health Economics Expert Panel in Qatar (Q-OHEP) by Hamad, Anas

Get full text
Get full text

IIS balances anti-proliferating (tumor-suppressive) and pro-proliferating (oncogenic) activities across tissue boundaries. by Wenjing Qi (142213)

“…In addition, BMP signaling in the somatic gonad also positively regulate germline proliferation, while DAF-16 in the germline has been proposed to inhibit cell proliferation (inhibitory activity in red) [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1006801#pgen.1006801.ref005" target="_blank">5</a>]. …”

Risk Factors for Delayed Entrance into Care after Diagnosis among Patients with Late-Stage HIV Disease in Southern Vietnam by Suresh Rangarajan (645683)

“…Independent predictors for delayed entry were feeling healthy (aOR 3.7, 95% CI 1.5–9.1), first positive HIV test at other site (aOR 2.9, CI 1.2–7.1), history of injection drug use (IDU) (aOR 2.9, 95% CI 1.1–7.9), work/school conflicts (aOR 4.3, 95% CI 1.7–10.8), prior registration at another clinic (aOR 77.4, 95% CI 8.6–697), detention or imprisonment (aOR 10.3, 95% CI 1.8–58.2), and perceived distance to clinic (aOR 3.7, 95% CI 1.0–13.7).…”

Data_Sheet_1_Robust Characteristics of the Laschamp and Mono Lake Geomagnetic Excursions: Results From Global Field Models.PDF by Monika Korte (4916491)

“…In contrast to the Laschamp, these excursions appear driven by smaller decreases in axial dipole field strength during a time when the axial dipole power at the CMB is similar to the power in the non-dipole field. …”

Data Sheet 1_Molecular mapping and validation of quantitative trait loci for content of micronutrients in wheat grain.docx by Xiangdong Chen (149352)

“…A total of 60 and 51 high-confidence annotated genes for QFe/Se.yaas-2D and QMn/Zn.yaas-4D were identified using the International Wheat Genome Sequencing Consortium Reference Sequence v2.1 (IWGSC RefSeq v2.1), respectively. …”

Data Sheet 2_Molecular mapping and validation of quantitative trait loci for content of micronutrients in wheat grain.docx by Xiangdong Chen (149352)

“…A total of 60 and 51 high-confidence annotated genes for QFe/Se.yaas-2D and QMn/Zn.yaas-4D were identified using the International Wheat Genome Sequencing Consortium Reference Sequence v2.1 (IWGSC RefSeq v2.1), respectively. …”

Mutation of <i>tp53</i> rescues the female-to-male sex-reversal phenotype of <i>fancl</i> mutants by reducing germ cell apoptosis. by Adriana Rodríguez-Marí (53698)

“…<p>(A) The distribution of individuals of different <i>tp53</i> genotypes among <i>fancl</i><b><i>^−/</i></b>^<b>−</b> homozygous mutant progeny (n = 44) from an in-cross of double heterozygotes (<i>fancl</i><b>^+/−</b><i>;tp53</i><b><i>^+/</i></b>^<b>−</b>) is shown in a bar graph representing the number of females (purple bar) and males (green bars) distributed according to their <i>tp53</i> genotypes (wild type, heterozygous or homozygous mutant). …”

The expression profiles of the selected IFNα-stimulated genes are negatively influenced by the intracellular factor IRF2. by Katharina Robichon (8445099)

“…(<b>D</b>) Upregulation of gene expression by decreased <i>IRF2</i> expression. Huh7.5 cells were incubated with 50 nM siRNA directed against <i>IRF2</i> (orange) or non-targeting control (blue) for 24 hours, and then treated with 500 U/ml IFNα. …”